Automation Market in Biopharmaceutical Industry - Top 3 Trends by Technavio

Technavio has published a new report on the global automation market in biopharmaceutical industry from 2017-2021. (Graphic: Business Wire)

LONDON--()--Technavio’s latest market research report on the global automation market in the biopharmaceutical industry provides an analysis of the most important trends expected to impact the market outlook from 2017-2021. Technavio defines an emerging trend as a factor that has the potential to significantly impact the market and contribute to its growth or decline.

The need for increasing flexibility, operational efficiency, and accuracy has led to the rapid deployment of automated components in the industry. Manufacturing of drugs requires precision and accuracy in measurement and testing processes, which can be met by leveraging automation. These factors will increase the demand for automation in the biopharmaceutical industry during the forecast period.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

The top three emerging market trends driving the global automation market in the biopharmaceutical industry according to Technavio research analysts are:

  • Continuous manufacturing
  • Development of laboratory automation control interface
  • Implementation of IoT in labs

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Continuous manufacturing

Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shutdown time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology. However, downstream processing is still under batch processing. Vendors are making continuous innovations to make the downstream processes into continuous processes.

“Successfully designing continuous operations requires in-depth knowledge of the processes to understand critical process parameters. This process development focuses on strategies to decline intermediate sample conditioning to maintain a continuous flow in different units. For instance, a process having fewer chromatographic steps and continuous flow of samples between steps will be more desirable for operations,” says Raghav Bharadwaj Shivaswamy, a lead analyst at Technavio for automation research.

Development of laboratory automation control interface

Biopharmaceutical labs need an interface to provide necessary information to users, which is known as laboratory information management system (LIMS). LIMS is a software that stores, reports, and manages data of a batch of samples that are tested for drug trials, and handles complex batch of data. It effectively manages sample specimens and improves lab efficiency.

The biopharmaceutical industry, being highly regulated, tracks the sample movement accurately and system check must be done continuously in a manufacturing process to attain quality and regulatory compliance. LIMS has been deployed to manage and analyze the sample with quick time turnaround. LIMS also provides extended efficiency in sample testing.

Implementation of IoT in labs

Internet of Things (IoT) is an interconnection of several things ranging from mechanical to digital devices that enable transforming the data without any involvement of human-human or human-computer interaction. It is a network between electromechanical devices with wireless technology offering microservices through the Internet.

“IoT has been extensively implemented in industries and now has also been introduced in healthcare laboratories. IoT has also enabled the creation of smart labs that are referred to as the Internet of Laboratory Things. IoLT enables the experts to operate the processes with high accuracy from anywhere and at any time. This type of remote monitoring was only possible due to the implementation of IoT with automated workstations in laboratories,” says Raghav.

Browse Related Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

Release Summary

Technavio’s latest market research report on the global automation market in biopharmaceutical industry analyses the key trends and drivers.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200